Nebula Research & Development’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,727
Closed -$344K 937
2024
Q3
$344K Buy
+6,727
New +$344K 0.04% 673